2,3-naphthalenedicarboxaldehyde and Amyloid Neuropathy Type 1

2,3-naphthalenedicarboxaldehyde has been researched along with Amyloid Neuropathy Type 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deslouis, C; Faure, M; Gamby, J; Haghiri-Gosnet, AM; Korchane, S; Le Potier, I; Pallandre, A	1

Other Studies

1 other study(ies) available for 2,3-naphthalenedicarboxaldehyde and Amyloid Neuropathy Type 1

Article	Year
Investigating of labelling and detection of transthyretin synthetic peptide derivatized with naphthalene-2,3-dicarboxaldehyde. Talanta, 2013, Nov-15, Volume: 116 Topics: Amino Acid Sequence; Amyloid Neuropathies, Familial; Carbon; Electrochemical Techniques; Electrodes; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Limit of Detection; Molecular Mimicry; Molecular Sequence Data; Naphthalenes; Osmolar Concentration; Peptides; Prealbumin; Solutions; Spectrometry, Fluorescence; Staining and Labeling; Trypsin	2013

Article

Year

Investigating of labelling and detection of transthyretin synthetic peptide derivatized with naphthalene-2,3-dicarboxaldehyde.

Talanta, 2013, Nov-15, Volume: 116

Topics: Amino Acid Sequence; Amyloid Neuropathies, Familial; Carbon; Electrochemical Techniques; Electrodes; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Limit of Detection; Molecular Mimicry; Molecular Sequence Data; Naphthalenes; Osmolar Concentration; Peptides; Prealbumin; Solutions; Spectrometry, Fluorescence; Staining and Labeling; Trypsin

2013